Increased apoptosis of Huntington disease lymphoblasts associated with repeat length-dependent mitochondrial depolarization

被引:312
作者
Sawa, A
Wiegand, GW
Cooper, J
Margolis, RL
Sharp, AH
Lawler, JF
Greenamyre, JT
Snyder, SH
Ross, CA
机构
[1] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA
[3] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA
[4] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA
[5] Johns Hopkins Univ, Sch Med, Program Cellular & Mol Med, Baltimore, MD 21205 USA
[6] Emory Univ, Dept Neurol, Atlanta, GA 30322 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1038/13518
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Huntington disease (HD) is a genetically dominant condition caused by expanded CAG repeats coding for glutamine in the HD gene product huntingtin(1). Although HD symptoms reflect preferential neuronal death in specific brain regions, huntingtin is expressed in almost all tissues(2), so abnormalities outside the brain might be expected. Although involvement of nuclei(3-7) and mitochondria(8-14) in HD pathophysiology has been suggested, specific intracellular defects that might elicit cell death have been unclear. Mitochondria dysfunction is reported in HD brains(10-13); mitochondria are organelles that regulates apoptotic cell death(15,16). We now report that lymphoblasts derived from HD patients showed increased stress-induced apoptotic cell death associated with caspase-3 activation. When subjected to stress, HD lymphoblasts also manifested a considerable increase in mitochondrial depolarization correlated with increased glutamine repeats.
引用
收藏
页码:1194 / 1198
页数:5
相关论文
共 34 条
  • [1] ANHOLT RRH, 1986, J BIOL CHEM, V261, P576
  • [2] GLUTAMATE-INDUCED NEURONAL DEATH - A SUCCESSION OF NECROSIS OR APOPTOSIS DEPENDING ON MITOCHONDRIAL-FUNCTION
    ANKARCRONA, M
    DYPBUKT, JM
    BONFOCO, E
    ZHIVOTOVSKY, B
    ORRENIUS, S
    LIPTON, SA
    NICOTERA, P
    [J]. NEURON, 1995, 15 (04) : 961 - 973
  • [3] Complex I defect in muscle from patients with Huntington's disease
    Arenas, J
    Campos, Y
    Ribacoba, R
    Martín, MA
    Rubio, JC
    Ablanedo, P
    Cabello, A
    [J]. ANNALS OF NEUROLOGY, 1998, 43 (03) : 397 - 400
  • [4] BEAL MF, 1993, J NEUROSCI, V13, P4181
  • [5] Intranuclear neuronal inclusions in Huntington's disease and dentatorubral and pallidoluysian atrophy: Correlation between the density of inclusions and IT15 CAG triplet repeat length
    Becher, MW
    Kotzuk, JA
    Sharp, AH
    Davies, SW
    Bates, GP
    Price, DL
    Ross, CA
    [J]. NEUROBIOLOGY OF DISEASE, 1998, 4 (06) : 387 - 397
  • [6] Oxidative damage and metabolic dysfunction in Huntington's disease: Selective vulnerability of the basal ganglia
    Browne, SE
    Bowling, AC
    MacGarvey, U
    Baik, MJ
    Berger, SC
    Muqit, MMK
    Bird, ED
    Beal, MF
    [J]. ANNALS OF NEUROLOGY, 1997, 41 (05) : 646 - 653
  • [7] Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation
    Davies, SW
    Turmaine, M
    Cozens, BA
    DiFiglia, M
    Sharp, AH
    Ross, CA
    Scherzinger, E
    Wanker, EE
    Mangiarini, L
    Bates, GP
    [J]. CELL, 1997, 90 (03) : 537 - 548
  • [8] Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain
    DiFiglia, M
    Sapp, E
    Chase, KO
    Davies, SW
    Bates, GP
    Vonsattel, JP
    Aronin, N
    [J]. SCIENCE, 1997, 277 (5334) : 1990 - 1993
  • [9] Mitochondria and apoptosis
    Green, DR
    Reed, JC
    [J]. SCIENCE, 1998, 281 (5381) : 1309 - 1312
  • [10] Mitochondrial defect in Huntington's disease on caudate nucleus
    Gu, M
    Gash, MT
    Mann, VM
    JavoyAgid, F
    Cooper, JM
    Schapira, AHV
    [J]. ANNALS OF NEUROLOGY, 1996, 39 (03) : 385 - 389